Summary
According to APO Research, The global β-Nicotinamide Mononucleotide (NMN) market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for β-Nicotinamide Mononucleotide (NMN) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for β-Nicotinamide Mononucleotide (NMN) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for β-Nicotinamide Mononucleotide (NMN) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for β-Nicotinamide Mononucleotide (NMN) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of β-Nicotinamide Mononucleotide (NMN) include GeneHarbor, Herbalmax, Genex Formulas, Shinkowa Pharmaceutical, Maac10 Formulas, EffePharm, Bontac, CELFULL and Kingdomway, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
In terms of production side, this report researches the β-Nicotinamide Mononucleotide (NMN) production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.
In terms of consumption side, this report focuses on the sales of β-Nicotinamide Mononucleotide (NMN) by region (region level and country level), by Company, by Type and by Application. from 2019 to 2024 and forecast to 2030.
This report presents an overview of global market for β-Nicotinamide Mononucleotide (NMN), capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of β-Nicotinamide Mononucleotide (NMN), also provides the consumption of main regions and countries. Of the upcoming market potential for β-Nicotinamide Mononucleotide (NMN), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the β-Nicotinamide Mononucleotide (NMN) sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global β-Nicotinamide Mononucleotide (NMN) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for β-Nicotinamide Mononucleotide (NMN) sales, projected growth trends, production technology, application and end-user industry.
β-Nicotinamide Mononucleotide (NMN) segment by Company
GeneHarbor
Herbalmax
Genex Formulas
Shinkowa Pharmaceutical
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway
β-Nicotinamide Mononucleotide (NMN) segment by Content
Above 98%
Below 98%
β-Nicotinamide Mononucleotide (NMN) segment by Application
Health Care Products
Cosmetics
Others
β-Nicotinamide Mononucleotide (NMN) segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global β-Nicotinamide Mononucleotide (NMN) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of β-Nicotinamide Mononucleotide (NMN) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of β-Nicotinamide Mononucleotide (NMN).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: β-Nicotinamide Mononucleotide (NMN) production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 4: Sales (consumption), revenue of β-Nicotinamide Mononucleotide (NMN) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 5: Detailed analysis of β-Nicotinamide Mononucleotide (NMN) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, β-Nicotinamide Mononucleotide (NMN) sales, revenue, price, gross margin, and recent development, etc.
Chapter 9: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 11: China by type, by application, sales, and revenue for each segment.
Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 13: Middle East, Africa, Latin America by type, by application and by country, sales, and revenue for each segment.
Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 15: The main concluding insights of the report.
1 Market Overview
1.1 Product Definition
1.2 β-Nicotinamide Mononucleotide (NMN) Market by Content
1.2.1 Global β-Nicotinamide Mononucleotide (NMN) Market Size by Content, 2019 VS 2023 VS 2030
1.2.2 Above 98%
1.2.3 Below 98%
1.3 β-Nicotinamide Mononucleotide (NMN) Market by Application
1.3.1 Global β-Nicotinamide Mononucleotide (NMN) Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Health Care Products
1.3.3 Cosmetics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 β-Nicotinamide Mononucleotide (NMN) Market Dynamics
2.1 β-Nicotinamide Mononucleotide (NMN) Industry Trends
2.2 β-Nicotinamide Mononucleotide (NMN) Industry Drivers
2.3 β-Nicotinamide Mononucleotide (NMN) Industry Opportunities and Challenges
2.4 β-Nicotinamide Mononucleotide (NMN) Industry Restraints
3 Global β-Nicotinamide Mononucleotide (NMN) Production Overview
3.1 Global β-Nicotinamide Mononucleotide (NMN) Production Capacity (2019-2030)
3.2 Global β-Nicotinamide Mononucleotide (NMN) Production by Region: 2019 VS 2023 VS 2030
3.3 Global β-Nicotinamide Mononucleotide (NMN) Production by Region
3.3.1 Global β-Nicotinamide Mononucleotide (NMN) Production by Region (2019-2024)
3.3.2 Global β-Nicotinamide Mononucleotide (NMN) Production by Region (2025-2030)
3.3.3 Global β-Nicotinamide Mononucleotide (NMN) Production Market Share by Region (2019-2030)
3.4 North America
3.5 Europe
3.6 China
3.7 Japan
4 Global Market Growth Prospects
4.1 Global β-Nicotinamide Mononucleotide (NMN) Revenue Estimates and Forecasts (2019-2030)
4.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Region
4.2.1 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Region: 2019 VS 2023 VS 2030
4.2.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Region (2019-2024)
4.2.3 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Region (2025-2030)
4.2.4 Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2019-2030)
4.3 Global β-Nicotinamide Mononucleotide (NMN) Sales Estimates and Forecasts 2019-2030
4.4 Global β-Nicotinamide Mononucleotide (NMN) Sales by Region
4.4.1 Global β-Nicotinamide Mononucleotide (NMN) Sales by Region: 2019 VS 2023 VS 2030
4.4.2 Global β-Nicotinamide Mononucleotide (NMN) Sales by Region (2019-2024)
4.4.3 Global β-Nicotinamide Mononucleotide (NMN) Sales by Region (2025-2030)
4.4.4 Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2019-2030)
4.5 US & Canada
4.6 Europe
4.7 China
4.8 Asia (Excluding China)
4.9 Middle East, Africa and Latin America
5 Market Competitive Landscape by Manufacturers
5.1 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Manufacturers
5.1.1 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Manufacturers (2019-2024)
5.1.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Manufacturers (2019-2024)
5.1.3 Global β-Nicotinamide Mononucleotide (NMN) Manufacturers Revenue Share Top 10 and Top 5 in 2023
5.2 Global β-Nicotinamide Mononucleotide (NMN) Sales by Manufacturers
5.2.1 Global β-Nicotinamide Mononucleotide (NMN) Sales by Manufacturers (2019-2024)
5.2.2 Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Manufacturers (2019-2024)
5.2.3 Global β-Nicotinamide Mononucleotide (NMN) Manufacturers Sales Share Top 10 and Top 5 in 2023
5.3 Global β-Nicotinamide Mononucleotide (NMN) Sales Price by Manufacturers (2019-2024)
5.4 Global β-Nicotinamide Mononucleotide (NMN) Key Manufacturers Ranking, 2022 VS 2023 VS 2024
5.5 Global β-Nicotinamide Mononucleotide (NMN) Key Manufacturers Manufacturing Sites & Headquarters
5.6 Global β-Nicotinamide Mononucleotide (NMN) Manufacturers, Product Type & Application
5.7 Global β-Nicotinamide Mononucleotide (NMN) Manufacturers Commercialization Time
5.8 Market Competitive Analysis
5.8.1 Global β-Nicotinamide Mononucleotide (NMN) Market CR5 and HHI
5.8.2 2023 β-Nicotinamide Mononucleotide (NMN) Tier 1, Tier 2, and Tier 3
6 β-Nicotinamide Mononucleotide (NMN) Market by Content
6.1 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Content
6.1.1 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2019 VS 2023 VS 2030)
6.1.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2019-2030) & (US$ Million)
6.1.3 Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Content (2019-2030)
6.2 Global β-Nicotinamide Mononucleotide (NMN) Sales by Content
6.2.1 Global β-Nicotinamide Mononucleotide (NMN) Sales by Content (2019 VS 2023 VS 2030)
6.2.2 Global β-Nicotinamide Mononucleotide (NMN) Sales by Content (2019-2030) & (Kg)
6.2.3 Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Content (2019-2030)
6.3 Global β-Nicotinamide Mononucleotide (NMN) Price by Content
7 β-Nicotinamide Mononucleotide (NMN) Market by Application
7.1 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Application
7.1.1 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2019 VS 2023 VS 2030)
7.1.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2019-2030) & (US$ Million)
7.1.3 Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2019-2030)
7.2 Global β-Nicotinamide Mononucleotide (NMN) Sales by Application
7.2.1 Global β-Nicotinamide Mononucleotide (NMN) Sales by Application (2019 VS 2023 VS 2030)
7.2.2 Global β-Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2030) & (Kg)
7.2.3 Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2019-2030)
7.3 Global β-Nicotinamide Mononucleotide (NMN) Price by Application
8 Company Profiles
8.1 GeneHarbor
8.1.1 GeneHarbor Comapny Information
8.1.2 GeneHarbor Business Overview
8.1.3 GeneHarbor β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
8.1.4 GeneHarbor β-Nicotinamide Mononucleotide (NMN) Product Portfolio
8.1.5 GeneHarbor Recent Developments
8.2 Herbalmax
8.2.1 Herbalmax Comapny Information
8.2.2 Herbalmax Business Overview
8.2.3 Herbalmax β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
8.2.4 Herbalmax β-Nicotinamide Mononucleotide (NMN) Product Portfolio
8.2.5 Herbalmax Recent Developments
8.3 Genex Formulas
8.3.1 Genex Formulas Comapny Information
8.3.2 Genex Formulas Business Overview
8.3.3 Genex Formulas β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
8.3.4 Genex Formulas β-Nicotinamide Mononucleotide (NMN) Product Portfolio
8.3.5 Genex Formulas Recent Developments
8.4 Shinkowa Pharmaceutical
8.4.1 Shinkowa Pharmaceutical Comapny Information
8.4.2 Shinkowa Pharmaceutical Business Overview
8.4.3 Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
8.4.4 Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Product Portfolio
8.4.5 Shinkowa Pharmaceutical Recent Developments
8.5 Maac10 Formulas
8.5.1 Maac10 Formulas Comapny Information
8.5.2 Maac10 Formulas Business Overview
8.5.3 Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
8.5.4 Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Product Portfolio
8.5.5 Maac10 Formulas Recent Developments
8.6 EffePharm
8.6.1 EffePharm Comapny Information
8.6.2 EffePharm Business Overview
8.6.3 EffePharm β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
8.6.4 EffePharm β-Nicotinamide Mononucleotide (NMN) Product Portfolio
8.6.5 EffePharm Recent Developments
8.7 Bontac
8.7.1 Bontac Comapny Information
8.7.2 Bontac Business Overview
8.7.3 Bontac β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
8.7.4 Bontac β-Nicotinamide Mononucleotide (NMN) Product Portfolio
8.7.5 Bontac Recent Developments
8.8 CELFULL
8.8.1 CELFULL Comapny Information
8.8.2 CELFULL Business Overview
8.8.3 CELFULL β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
8.8.4 CELFULL β-Nicotinamide Mononucleotide (NMN) Product Portfolio
8.8.5 CELFULL Recent Developments
8.9 Kingdomway
8.9.1 Kingdomway Comapny Information
8.9.2 Kingdomway Business Overview
8.9.3 Kingdomway β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
8.9.4 Kingdomway β-Nicotinamide Mononucleotide (NMN) Product Portfolio
8.9.5 Kingdomway Recent Developments
9 North America
9.1 North America β-Nicotinamide Mononucleotide (NMN) Market Size by Content
9.1.1 North America β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2019-2030)
9.1.2 North America β-Nicotinamide Mononucleotide (NMN) Sales by Content (2019-2030)
9.1.3 North America β-Nicotinamide Mononucleotide (NMN) Price by Content (2019-2030)
9.2 North America β-Nicotinamide Mononucleotide (NMN) Market Size by Application
9.2.1 North America β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2019-2030)
9.2.2 North America β-Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2030)
9.2.3 North America β-Nicotinamide Mononucleotide (NMN) Price by Application (2019-2030)
9.3 North America β-Nicotinamide Mononucleotide (NMN) Market Size by Country
9.3.1 North America β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 North America β-Nicotinamide Mononucleotide (NMN) Sales by Country (2019 VS 2023 VS 2030)
9.3.3 North America β-Nicotinamide Mononucleotide (NMN) Price by Country (2019-2030)
9.3.4 United States
9.3.5 Canada
10 Europe
10.1 Europe β-Nicotinamide Mononucleotide (NMN) Market Size by Content
10.1.1 Europe β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2019-2030)
10.1.2 Europe β-Nicotinamide Mononucleotide (NMN) Sales by Content (2019-2030)
10.1.3 Europe β-Nicotinamide Mononucleotide (NMN) Price by Content (2019-2030)
10.2 Europe β-Nicotinamide Mononucleotide (NMN) Market Size by Application
10.2.1 Europe β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2019-2030)
10.2.2 Europe β-Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2030)
10.2.3 Europe β-Nicotinamide Mononucleotide (NMN) Price by Application (2019-2030)
10.3 Europe β-Nicotinamide Mononucleotide (NMN) Market Size by Country
10.3.1 Europe β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
10.3.2 Europe β-Nicotinamide Mononucleotide (NMN) Sales by Country (2019 VS 2023 VS 2030)
10.3.3 Europe β-Nicotinamide Mononucleotide (NMN) Price by Country (2019-2030)
10.3.4 Germany
10.3.5 France
10.3.6 U.K.
10.3.7 Italy
10.3.8 Russia
11 China
11.1 China β-Nicotinamide Mononucleotide (NMN) Market Size by Content
11.1.1 China β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2019-2030)
11.1.2 China β-Nicotinamide Mononucleotide (NMN) Sales by Content (2019-2030)
11.1.3 China β-Nicotinamide Mononucleotide (NMN) Price by Content (2019-2030)
11.2 China β-Nicotinamide Mononucleotide (NMN) Market Size by Application
11.2.1 China β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2019-2030)
11.2.2 China β-Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2030)
11.2.3 China β-Nicotinamide Mononucleotide (NMN) Price by Application (2019-2030)
12 Asia (Excluding China)
12.1 Asia β-Nicotinamide Mononucleotide (NMN) Market Size by Content
12.1.1 Asia β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2019-2030)
12.1.2 Asia β-Nicotinamide Mononucleotide (NMN) Sales by Content (2019-2030)
12.1.3 Asia β-Nicotinamide Mononucleotide (NMN) Price by Content (2019-2030)
12.2 Asia β-Nicotinamide Mononucleotide (NMN) Market Size by Application
12.2.1 Asia β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2019-2030)
12.2.2 Asia β-Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2030)
12.2.3 Asia β-Nicotinamide Mononucleotide (NMN) Price by Application (2019-2030)
12.3 Asia β-Nicotinamide Mononucleotide (NMN) Market Size by Country
12.3.1 Asia β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 Asia β-Nicotinamide Mononucleotide (NMN) Sales by Country (2019 VS 2023 VS 2030)
12.3.3 Asia β-Nicotinamide Mononucleotide (NMN) Price by Country (2019-2030)
12.3.4 Japan
12.3.5 South Korea
12.3.6 India
12.3.7 Australia
12.3.8 China Taiwan
12.3.9 Southeast Asia
13 Middle East, Africa and Latin America
13.1 Middle East, Africa and Latin America β-Nicotinamide Mononucleotide (NMN) Market Size by Content
13.1.1 Middle East, Africa and Latin America β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2019-2030)
13.1.2 Middle East, Africa and Latin America β-Nicotinamide Mononucleotide (NMN) Sales by Content (2019-2030)
13.1.3 Middle East, Africa and Latin America β-Nicotinamide Mononucleotide (NMN) Price by Content (2019-2030)
13.2 Middle East, Africa and Latin America β-Nicotinamide Mononucleotide (NMN) Market Size by Application
13.2.1 Middle East, Africa and Latin America β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2019-2030)
13.2.2 Middle East, Africa and Latin America β-Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2030)
13.2.3 Middle East, Africa and Latin America β-Nicotinamide Mononucleotide (NMN) Price by Application (2019-2030)
13.3 Middle East, Africa and Latin America β-Nicotinamide Mononucleotide (NMN) Market Size by Country
13.3.1 Middle East, Africa and Latin America β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
13.3.2 Middle East, Africa and Latin America β-Nicotinamide Mononucleotide (NMN) Sales by Country (2019 VS 2023 VS 2030)
13.3.3 Middle East, Africa and Latin America β-Nicotinamide Mononucleotide (NMN) Price by Country (2019-2030)
13.3.4 Mexico
13.3.5 Brazil
13.3.6 Israel
13.3.7 Argentina
13.3.8 Colombia
13.3.9 Turkey
13.3.10 Saudi Arabia
13.3.11 UAE
14 Value Chain and Sales Channels Analysis
14.1 β-Nicotinamide Mononucleotide (NMN) Value Chain Analysis
14.1.1 β-Nicotinamide Mononucleotide (NMN) Key Raw Materials
14.1.2 Raw Materials Key Suppliers
14.1.3 Manufacturing Cost Structure
14.1.4 β-Nicotinamide Mononucleotide (NMN) Production Mode & Process
14.2 β-Nicotinamide Mononucleotide (NMN) Sales Channels Analysis
14.2.1 Direct Comparison with Distribution Share
14.2.2 β-Nicotinamide Mononucleotide (NMN) Distributors
14.2.3 β-Nicotinamide Mononucleotide (NMN) Customers
15 Concluding Insights
16 Appendix
16.1 Reasons for Doing This Study
16.2 Research Methodology
16.3 Research Process
16.4 Authors List of This Report
16.5 Data Source
16.5.1 Secondary Sources
16.5.2 Primary Sources
16.6 Disclaimer
List of Tables
Table 1. Global β-Nicotinamide Mononucleotide (NMN) Market Size Growth Rate by Content (US$ Million), 2019 VS 2023 VS 2030
Table 2. Global β-Nicotinamide Mononucleotide (NMN) Market Size Growth Rate by Content (US$ Million), 2019 VS 2023 VS 2030
Table 3. Above 98% Major Manufacturers
Table 4. Below 98% Major Manufacturers
Table 5. Global β-Nicotinamide Mononucleotide (NMN) Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 6. Health Care Products Major Manufacturers
Table 7. Cosmetics Major Manufacturers
Table 8. Others Major Manufacturers
Table 9. β-Nicotinamide Mononucleotide (NMN) Industry Trends
Table 10. β-Nicotinamide Mononucleotide (NMN) Industry Drivers
Table 11. β-Nicotinamide Mononucleotide (NMN) Industry Opportunities and Challenges
Table 12. β-Nicotinamide Mononucleotide (NMN) Industry Restraints
Table 13. Global β-Nicotinamide Mononucleotide (NMN) Production Growth Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (Kg)
Table 14. Global β-Nicotinamide Mononucleotide (NMN) Production by Region (2019-2024) & (Kg)
Table 15. Global β-Nicotinamide Mononucleotide (NMN) Production by Region (2025-2030) & (Kg)
Table 16. Global β-Nicotinamide Mononucleotide (NMN) Production Market Share by Region (2019-2024)
Table 17. Global β-Nicotinamide Mononucleotide (NMN) Production Market Share by Region (2025-2030)
Table 18. Global β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Region (2019-2024) & (US$ Million)
Table 20. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Region (2025-2030) & (US$ Million)
Table 21. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2019-2024)
Table 22. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2025-2030)
Table 23. Global β-Nicotinamide Mononucleotide (NMN) Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (Kg)
Table 24. Global β-Nicotinamide Mononucleotide (NMN) Sales by Region (2019-2024) & (Kg)
Table 25. Global β-Nicotinamide Mononucleotide (NMN) Sales by Region (2025-2030) & (Kg)
Table 26. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2019-2024)
Table 27. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2025-2030)
Table 28. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 29. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Manufacturers (2019-2024)
Table 30. Global β-Nicotinamide Mononucleotide (NMN) Sales by Manufacturers (US$ Million) & (2019-2024)
Table 31. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Manufacturers (2019-2024)
Table 32. Global β-Nicotinamide Mononucleotide (NMN) Sales Price (US$/Kg) of Manufacturers (2019-2024)
Table 33. Global β-Nicotinamide Mononucleotide (NMN) Key Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 34. Global β-Nicotinamide Mononucleotide (NMN) Key Manufacturers Manufacturing Sites & Headquarters
Table 35. Global β-Nicotinamide Mononucleotide (NMN) Manufacturers, Product Type & Application
Table 36. Global β-Nicotinamide Mononucleotide (NMN) Manufacturers Commercialization Time
Table 37. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 38. Global β-Nicotinamide Mononucleotide (NMN) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 39. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Content 2019 VS 2023 VS 2030 (US$ Million)
Table 40. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2019-2024) & (US$ Million)
Table 41. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2025-2030) & (US$ Million)
Table 42. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Content (2019-2024)
Table 43. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Content (2025-2030)
Table 44. Global β-Nicotinamide Mononucleotide (NMN) Sales by Content 2019 VS 2023 VS 2030 (Kg)
Table 45. Global β-Nicotinamide Mononucleotide (NMN) Sales by Content (2019-2024) & (Kg)
Table 46. Global β-Nicotinamide Mononucleotide (NMN) Sales by Content (2025-2030) & (Kg)
Table 47. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Content (2019-2024)
Table 48. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Content (2025-2030)
Table 49. Global β-Nicotinamide Mononucleotide (NMN) Price by Content (2019-2024) & (US$/Kg)
Table 50. Global β-Nicotinamide Mononucleotide (NMN) Price by Content (2025-2030) & (US$/Kg)
Table 51. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 52. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2019-2024) & (US$ Million)
Table 53. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2025-2030) & (US$ Million)
Table 54. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2019-2024)
Table 55. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2025-2030)
Table 56. Global β-Nicotinamide Mononucleotide (NMN) Sales by Application 2019 VS 2023 VS 2030 (Kg)
Table 57. Global β-Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2024) & (Kg)
Table 58. Global β-Nicotinamide Mononucleotide (NMN) Sales by Application (2025-2030) & (Kg)
Table 59. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2019-2024)
Table 60. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2025-2030)
Table 61. Global β-Nicotinamide Mononucleotide (NMN) Price by Application (2019-2024) & (US$/Kg)
Table 62. Global β-Nicotinamide Mononucleotide (NMN) Price by Application (2025-2030) & (US$/Kg)
Table 63. GeneHarbor Company Information
Table 64. GeneHarbor Business Overview
Table 65. GeneHarbor β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 66. GeneHarbor β-Nicotinamide Mononucleotide (NMN) Product Portfolio
Table 67. GeneHarbor Recent Development
Table 68. Herbalmax Company Information
Table 69. Herbalmax Business Overview
Table 70. Herbalmax β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 71. Herbalmax β-Nicotinamide Mononucleotide (NMN) Product Portfolio
Table 72. Herbalmax Recent Development
Table 73. Genex Formulas Company Information
Table 74. Genex Formulas Business Overview
Table 75. Genex Formulas β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 76. Genex Formulas β-Nicotinamide Mononucleotide (NMN) Product Portfolio
Table 77. Genex Formulas Recent Development
Table 78. Shinkowa Pharmaceutical Company Information
Table 79. Shinkowa Pharmaceutical Business Overview
Table 80. Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 81. Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Product Portfolio
Table 82. Shinkowa Pharmaceutical Recent Development
Table 83. Maac10 Formulas Company Information
Table 84. Maac10 Formulas Business Overview
Table 85. Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 86. Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Product Portfolio
Table 87. Maac10 Formulas Recent Development
Table 88. EffePharm Company Information
Table 89. EffePharm Business Overview
Table 90. EffePharm β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 91. EffePharm β-Nicotinamide Mononucleotide (NMN) Product Portfolio
Table 92. EffePharm Recent Development
Table 93. Bontac Company Information
Table 94. Bontac Business Overview
Table 95. Bontac β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 96. Bontac β-Nicotinamide Mononucleotide (NMN) Product Portfolio
Table 97. Bontac Recent Development
Table 98. CELFULL Company Information
Table 99. CELFULL Business Overview
Table 100. CELFULL β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 101. CELFULL β-Nicotinamide Mononucleotide (NMN) Product Portfolio
Table 102. CELFULL Recent Development
Table 103. Kingdomway Company Information
Table 104. Kingdomway Business Overview
Table 105. Kingdomway β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 106. Kingdomway β-Nicotinamide Mononucleotide (NMN) Product Portfolio
Table 107. Kingdomway Recent Development
Table 108. North America β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2019-2024) & (US$ Million)
Table 109. North America β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2025-2030) & (US$ Million)
Table 110. North America β-Nicotinamide Mononucleotide (NMN) Sales by Content (2019-2024) & (Kg)
Table 111. North America β-Nicotinamide Mononucleotide (NMN) Sales by Content (2025-2030) & (Kg)
Table 112. North America β-Nicotinamide Mononucleotide (NMN) Sales Price by Content (2019-2024) & (US$/Kg)
Table 113. North America β-Nicotinamide Mononucleotide (NMN) Sales Price by Content (2025-2030) & (US$/Kg)
Table 114. North America β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2019-2024) & (US$ Million)
Table 115. North America β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2025-2030) & (US$ Million)
Table 116. North America β-Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2024) & (Kg)
Table 117. North America β-Nicotinamide Mononucleotide (NMN) Sales by Application (2025-2030) & (Kg)
Table 118. North America β-Nicotinamide Mononucleotide (NMN) Sales Price by Application (2019-2024) & (US$/Kg)
Table 119. North America β-Nicotinamide Mononucleotide (NMN) Sales Price by Application (2025-2030) & (US$/Kg)
Table 120. North America β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 121. North America β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 122. North America β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 123. North America β-Nicotinamide Mononucleotide (NMN) Sales by Country (2019 VS 2023 VS 2030) & (Kg)
Table 124. North America β-Nicotinamide Mononucleotide (NMN) Sales by Country (2019-2024) & (Kg)
Table 125. North America β-Nicotinamide Mononucleotide (NMN) Sales by Country (2025-2030) & (Kg)
Table 126. North America β-Nicotinamide Mononucleotide (NMN) Sales Price by Country (2019-2024) & (US$/Kg)
Table 127. North America β-Nicotinamide Mononucleotide (NMN) Sales Price by Country (2025-2030) & (US$/Kg)
Table 128. United States β-Nicotinamide Mononucleotide (NMN) Revenue (2019-2030) & (US$ Million)
Table 129. Canada β-Nicotinamide Mononucleotide (NMN) Revenue (2019-2030) & (US$ Million)
Table 130. Europe β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2019-2024) & (US$ Million)
Table 131. Europe β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2025-2030) & (US$ Million)
Table 132. Europe β-Nicotinamide Mononucleotide (NMN) Sales by Content (2019-2024) & (Kg)
Table 133. Europe β-Nicotinamide Mononucleotide (NMN) Sales by Content (2025-2030) & (Kg)
Table 134. Europe β-Nicotinamide Mononucleotide (NMN) Sales Price by Content (2019-2024) & (US$/Kg)
Table 135. Europe β-Nicotinamide Mononucleotide (NMN) Sales Price by Content (2025-2030) & (US$/Kg)
Table 136. Europe β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2019-2024) & (US$ Million)
Table 137. Europe β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2025-2030) & (US$ Million)
Table 138. Europe β-Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2024) & (Kg)
Table 139. Europe β-Nicotinamide Mononucleotide (NMN) Sales by Application (2025-2030) & (Kg)
Table 140. Europe β-Nicotinamide Mononucleotide (NMN) Sales Price by Application (2019-2024) & (US$/Kg)
Table 141. Europe β-Nicotinamide Mononucleotide (NMN) Sales Price by Application (2025-2030) & (US$/Kg)
Table 142. Europe β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 143. Europe β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 144. Europe β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 145. Europe β-Nicotinamide Mononucleotide (NMN) Sales by Country (2019 VS 2023 VS 2030) & (Kg)
Table 146. Europe β-Nicotinamide Mononucleotide (NMN) Sales by Country (2019-2024) & (Kg)
Table 147. Europe β-Nicotinamide Mononucleotide (NMN) Sales by Country (2025-2030) & (Kg)
Table 148. Europe β-Nicotinamide Mononucleotide (NMN) Sales Price by Country (2019-2024) & (US$/Kg)
Table 149. Europe β-Nicotinamide Mononucleotide (NMN) Sales Price by Country (2025-2030) & (US$/Kg)
Table 150. Germany β-Nicotinamide Mononucleotide (NMN) Revenue (2019-2030) & (US$ Million)
Table 151. France β-Nicotinamide Mononucleotide (NMN) Revenue (2019-2030) & (US$ Million)
Table 152. β-Nicotinamide Mononucleotide (NMN) Revenue (2019-2030) & (US$ Million)
Table 153. β-Nicotinamide Mononucleotide (NMN) Revenue (2019-2030) & (US$ Million)
Table 154. β-Nicotinamide Mononucleotide (NMN) Revenue (2019-2030) & (US$ Million)
Table 155. China β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2019-2024) & (US$ Million)
Table 156. China β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2025-2030) & (US$ Million)
Table 157. China β-Nicotinamide Mononucleotide (NMN) Sales by Content (2019-2024) & (Kg)
Table 158. China β-Nicotinamide Mononucleotide (NMN) Sales by Content (2025-2030) & (Kg)
Table 159. China β-Nicotinamide Mononucleotide (NMN) Sales Price by Content (2019-2024) & (US$/Kg)
Table 160. China β-Nicotinamide Mononucleotide (NMN) Sales Price by Content (2025-2030) & (US$/Kg)
Table 161. China β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2019-2024) & (US$ Million)
Table 162. China β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2025-2030) & (US$ Million)
Table 163. China β-Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2024) & (Kg)
Table 164. China β-Nicotinamide Mononucleotide (NMN) Sales by Application (2025-2030) & (Kg)
Table 165. China β-Nicotinamide Mononucleotide (NMN) Sales Price by Application (2019-2024) & (US$/Kg)
Table 166. China β-Nicotinamide Mononucleotide (NMN) Sales Price by Application (2025-2030) & (US$/Kg)
Table 167. Asia β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2019-2024) & (US$ Million)
Table 168. Asia β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2025-2030) & (US$ Million)
Table 169. Asia β-Nicotinamide Mononucleotide (NMN) Sales by Content (2019-2024) & (Kg)
Table 170. Asia β-Nicotinamide Mononucleotide (NMN) Sales by Content (2025-2030) & (Kg)
Table 171. Asia β-Nicotinamide Mononucleotide (NMN) Sales Price by Content (2019-2024) & (US$/Kg)
Table 172. Asia β-Nicotinamide Mononucleotide (NMN) Sales Price by Content (2025-2030) & (US$/Kg)
Table 173. Asia β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2019-2024) & (US$ Million)
Table 174. Asia β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2025-2030) & (US$ Million)
Table 175. Asia β-Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2024) & (Kg)
Table 176. Asia β-Nicotinamide Mononucleotide (NMN) Sales by Application (2025-2030) & (Kg)
Table 177. Asia β-Nicotinamide Mononucleotide (NMN) Sales Price by Application (2019-2024) & (US$/Kg)
Table 178. Asia β-Nicotinamide Mononucleotide (NMN) Sales Price by Application (2025-2030) & (US$/Kg)
Table 179. Asia β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 180. Asia β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 181. Asia β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 182. Asia β-Nicotinamide Mononucleotide (NMN) Sales by Country (2019 VS 2023 VS 2030) & (Kg)
Table 183. Asia β-Nicotinamide Mononucleotide (NMN) Sales by Country (2019-2024) & (Kg)
Table 184. Asia β-Nicotinamide Mononucleotide (NMN) Sales by Country (2025-2030) & (Kg)
Table 185. Asia β-Nicotinamide Mononucleotide (NMN) Sales Price by Country (2019-2024) & (US$/Kg)
Table 186. Asia β-Nicotinamide Mononucleotide (NMN) Sales Price by Country (2025-2030) & (US$/Kg)
Table 187. Japan β-Nicotinamide Mononucleotide (NMN) Revenue (2019-2030) & (US$ Million)
Table 188. South Korea β-Nicotinamide Mononucleotide (NMN) Revenue (2019-2030) & (US$ Million)
Table 189. β-Nicotinamide Mononucleotide (NMN) Revenue (2019-2030) & (US$ Million)
Table 190. β-Nicotinamide Mononucleotide (NMN) Revenue (2019-2030) & (US$ Million)
Table 191. β-Nicotinamide Mononucleotide (NMN) Revenue (2019-2030) & (US$ Million)
Table 192. β-Nicotinamide Mononucleotide (NMN) Revenue (2019-2030) & (US$ Million)
Table 193. β-Nicotinamide Mononucleotide (NMN) Revenue (2019-2030) & (US$ Million)
Table 194. β-Nicotinamide Mononucleotide (NMN) Revenue (2019-2030) & (US$ Million)
Table 195. MEALA β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2019-2024) & (US$ Million)
Table 196. MEALA β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2025-2030) & (US$ Million)
Table 197. MEALA β-Nicotinamide Mononucleotide (NMN) Sales by Content (2019-2024) & (Kg)
Table 198. MEALA β-Nicotinamide Mononucleotide (NMN) Sales by Content (2025-2030) & (Kg)
Table 199. MEALA β-Nicotinamide Mononucleotide (NMN) Sales Price by Content (2019-2024) & (US$/Kg)
Table 200. MEALA β-Nicotinamide Mononucleotide (NMN) Sales Price by Content (2025-2030) & (US$/Kg)
Table 201. MEALA β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2019-2024) & (US$ Million)
Table 202. MEALA β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2025-2030) & (US$ Million)
Table 203. MEALA β-Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2024) & (Kg)
Table 204. MEALA β-Nicotinamide Mononucleotide (NMN) Sales by Application (2025-2030) & (Kg)
Table 205. MEALA β-Nicotinamide Mononucleotide (NMN) Sales Price by Application (2019-2024) & (US$/Kg)
Table 206. MEALA β-Nicotinamide Mononucleotide (NMN) Sales Price by Application (2025-2030) & (US$/Kg)
Table 207. MEALA β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 208. MEALA β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 209. MEALA β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 210. MEALA β-Nicotinamide Mononucleotide (NMN) Sales by Country (2019 VS 2023 VS 2030) & (Kg)
Table 211. MEALA β-Nicotinamide Mononucleotide (NMN) Sales by Country (2019-2024) & (Kg)
Table 212. MEALA β-Nicotinamide Mononucleotide (NMN) Sales by Country (2025-2030) & (Kg)
Table 213. MEALA β-Nicotinamide Mononucleotide (NMN) Sales Price by Country (2019-2024) & (US$/Kg)
Table 214. MEALA β-Nicotinamide Mononucleotide (NMN) Sales Price by Country (2025-2030) & (US$/Kg)
Table 215. Mexico β-Nicotinamide Mononucleotide (NMN) Revenue (2019-2030) & (US$ Million)
Table 216. Brazil β-Nicotinamide Mononucleotide (NMN) Revenue (2019-2030) & (US$ Million)
Table 217. Israel β-Nicotinamide Mononucleotide (NMN) Revenue (2019-2030) & (US$ Million)
Table 218. Argentina β-Nicotinamide Mononucleotide (NMN) Revenue (2019-2030) & (US$ Million)
Table 219. Colombia β-Nicotinamide Mononucleotide (NMN) Revenue (2019-2030) & (US$ Million)
Table 220. Turkey β-Nicotinamide Mononucleotide (NMN) Revenue (2019-2030) & (US$ Million)
Table 221. Saudi Arabia β-Nicotinamide Mononucleotide (NMN) Revenue (2019-2030) & (US$ Million)
Table 222. UAE β-Nicotinamide Mononucleotide (NMN) Revenue (2019-2030) & (US$ Million)
Table 223. Key Raw Materials
Table 224. Raw Materials Key Suppliers
Table 225. β-Nicotinamide Mononucleotide (NMN) Distributors List
Table 226. β-Nicotinamide Mononucleotide (NMN) Customers List
Table 227. Research Programs/Design for This Report
Table 228. Authors List of This Report
Table 229. Secondary Sources
Table 230. Primary Sources
List of Figures
Figure 1. β-Nicotinamide Mononucleotide (NMN) Product Picture
Figure 2. Global β-Nicotinamide Mononucleotide (NMN) Market Size Growth Rate by Content (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global β-Nicotinamide Mononucleotide (NMN) Market Size Share 2019 VS 2023 VS 2030
Figure 4. Above 98% Picture
Figure 5. Below 98% Picture
Figure 6. Global β-Nicotinamide Mononucleotide (NMN) Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 7. Global β-Nicotinamide Mononucleotide (NMN) Market Size Share 2019 VS 2023 VS 2030
Figure 8. Health Care Products Picture
Figure 9. Cosmetics Picture
Figure 10. Others Picture
Figure 11. Global β-Nicotinamide Mononucleotide (NMN) Capacity, Production and Utilization (2019-2030) & (Kg)
Figure 12. Global β-Nicotinamide Mononucleotide (NMN) Production by Region: 2019 VS 2023 VS 2030 (Kg)
Figure 13. Global β-Nicotinamide Mononucleotide (NMN) Production Market Share by Region: 2023 Versus 2030
Figure 14. Global β-Nicotinamide Mononucleotide (NMN) Production Market Share by Region (2019-2030)
Figure 15. North America β-Nicotinamide Mononucleotide (NMN) Production Growth Rate (2019-2030) & (Kg)
Figure 16. North America Major Manufacturers
Figure 17. Europe Major Manufacturers
Figure 18. China Major Manufacturers
Figure 19. Japan Major Manufacturers
Figure 20. Region Five β-Nicotinamide Mononucleotide (NMN) Production Growth Rate (2019-2030) & (Kg)
Figure 21. Region Six β-Nicotinamide Mononucleotide (NMN) Production Growth Rate (2019-2030) & (Kg)
Figure 22. Region Seven β-Nicotinamide Mononucleotide (NMN) Production Growth Rate (2019-2030) & (Kg)
Figure 23. Region Eight β-Nicotinamide Mononucleotide (NMN) Production Growth Rate (2019-2030) & (Kg)
Figure 24. Region Nine β-Nicotinamide Mononucleotide (NMN) Production Growth Rate (2019-2030) & (Kg)
Figure 25. Global β-Nicotinamide Mononucleotide (NMN) Revenue (US$ Million), 2019 VS 2023 VS 2030
Figure 26. Global β-Nicotinamide Mononucleotide (NMN) Revenue (2019-2030) & (US$ Million)
Figure 27. Global β-Nicotinamide Mononucleotide (NMN) Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 28. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region: 2023 Versus 2030
Figure 29. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2019-2030)
Figure 30. Global β-Nicotinamide Mononucleotide (NMN) Sales (2019-2030) & (Kg)
Figure 31. Global β-Nicotinamide Mononucleotide (NMN) Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (Kg)
Figure 32. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2019-2030)
Figure 33. US & Canada β-Nicotinamide Mononucleotide (NMN) Sales YoY (2019-2030) & (Kg)
Figure 34. Europe β-Nicotinamide Mononucleotide (NMN) Sales YoY (2019-2030) & (Kg)
Figure 35. China β-Nicotinamide Mononucleotide (NMN) Sales YoY (2019-2030) & (Kg)
Figure 36. Asia (Excluding China) β-Nicotinamide Mononucleotide (NMN) Sales YoY (2019-2030) & (Kg)
Figure 37. Middle East, Africa and Latin America (Excluding China) β-Nicotinamide Mononucleotide (NMN) Sales YoY (2019-2030) & (Kg)
Figure 38. Global β-Nicotinamide Mononucleotide (NMN) Manufacturers Revenue Share Top 10 and Top 5 in 2023
Figure 39. Global β-Nicotinamide Mononucleotide (NMN) Manufacturers Sales Share Top 10 and Top 5 in 2023
Figure 40. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 41. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2019 VS 2023 VS 2030) & (US$ Million)
Figure 42. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share 2019 VS 2023 VS 2030
Figure 43. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Content (2019-2030)
Figure 44. Global β-Nicotinamide Mononucleotide (NMN) Sales by Content (2019 VS 2023 VS 2030) & (Kg)
Figure 45. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type 2019 VS 2023 VS 2030
Figure 46. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Content (2019-2030)
Figure 47. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 48. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application 2019 VS 2023 VS 2030
Figure 49. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2019-2030)
Figure 50. Global β-Nicotinamide Mononucleotide (NMN) Sales by Application (2019 VS 2023 VS 2030) & (Kg)
Figure 51. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application 2019 VS 2023 VS 2030
Figure 52. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2019-2030)
Figure 53. North America β-Nicotinamide Mononucleotide (NMN) Revenue Share by Content (2019-2030)
Figure 54. North America β-Nicotinamide Mononucleotide (NMN) Sales Share by Content (2019-2030)
Figure 55. North America β-Nicotinamide Mononucleotide (NMN) Revenue Share by Application (2019-2030)
Figure 56. North America β-Nicotinamide Mononucleotide (NMN) Sales Share by Application (2019-2030)
Figure 57. North America β-Nicotinamide Mononucleotide (NMN) Revenue Share by Country (2019-2030)
Figure 58. North America β-Nicotinamide Mononucleotide (NMN) Sales Share by Country (2019-2030)
Figure 59. Europe β-Nicotinamide Mononucleotide (NMN) Revenue Share by Content (2019-2030)
Figure 60. Europe β-Nicotinamide Mononucleotide (NMN) Sales Share by Content (2019-2030)
Figure 61. Europe β-Nicotinamide Mononucleotide (NMN) Revenue Share by Application (2019-2030)
Figure 62. Europe β-Nicotinamide Mononucleotide (NMN) Sales Share by Application (2019-2030)
Figure 63. Europe β-Nicotinamide Mononucleotide (NMN) Revenue Share by Country (2019-2030)
Figure 64. Europe β-Nicotinamide Mononucleotide (NMN) Sales Share by Country (2019-2030)
Figure 65. China β-Nicotinamide Mononucleotide (NMN) Revenue Share by Content (2019-2030)
Figure 66. China β-Nicotinamide Mononucleotide (NMN) Sales Share by Content (2019-2030)
Figure 67. China β-Nicotinamide Mononucleotide (NMN) Revenue Share by Application (2019-2030)
Figure 68. China β-Nicotinamide Mononucleotide (NMN) Sales Share by Application (2019-2030)
Figure 69. Asia β-Nicotinamide Mononucleotide (NMN) Revenue Share by Content (2019-2030)
Figure 70. Asia β-Nicotinamide Mononucleotide (NMN) Sales Share by Content (2019-2030)
Figure 71. Asia β-Nicotinamide Mononucleotide (NMN) Revenue Share by Application (2019-2030)
Figure 72. Asia β-Nicotinamide Mononucleotide (NMN) Sales Share by Application (2019-2030)
Figure 73. Asia β-Nicotinamide Mononucleotide (NMN) Revenue Share by Country (2019-2030)
Figure 74. Asia β-Nicotinamide Mononucleotide (NMN) Sales Share by Country (2019-2030)
Figure 75. MEALA β-Nicotinamide Mononucleotide (NMN) Revenue Share by Content (2019-2030)
Figure 76. MEALA β-Nicotinamide Mononucleotide (NMN) Sales Share by Content (2019-2030)
Figure 77. MEALA β-Nicotinamide Mononucleotide (NMN) Revenue Share by Application (2019-2030)
Figure 78. MEALA β-Nicotinamide Mononucleotide (NMN) Sales Share by Application (2019-2030)
Figure 79. MEALA β-Nicotinamide Mononucleotide (NMN) Revenue Share by Country (2019-2030)
Figure 80. MEALA β-Nicotinamide Mononucleotide (NMN) Sales Share by Country (2019-2030)
Figure 81. β-Nicotinamide Mononucleotide (NMN) Value Chain
Figure 82. Manufacturing Cost Structure
Figure 83. β-Nicotinamide Mononucleotide (NMN) Production Mode & Process
Figure 84. Direct Comparison with Distribution Share
Figure 85. Distributors Profiles
Figure 86. Years Considered
Figure 87. Research Process
Figure 88. Key Executives Interviewed
